EVMN
Evommune, Inc.
NYSE · Healthcare · Biotechnology · US
$5.27
+1.93%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 57.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.69x
- Price / sales
- 19.13x
- Price / cash flow
- -2.58x
Enterprise value
- Enterprise value
- -$1.4M
- EV / sales
- -0.14x
- EV / EBITDA
- 0.01x
- EV / EBIT
- 0.01x
- Market cap
- $191.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026